Download Product Catalogue

Product Detail

Cryptaz-AV 2.5

Cryptaz-AV 2.5

Ceftazidime 2 GM +Avibactum 0.5 GM

Ceftazidime: third-generation cephalosporin antibiotic which kills bacteria by inhibiting cell wall synthesis.

Ceftazidime: third-generation cephalosporin antibiotic which kills bacteria by inhibiting cell wall synthesis. Avibactam: new beta-lactamase inhibitor that prevents the resistance enzymes (ESBLs, Amp C, KPC, OXA-48) against ceftazidime and thus it is effective against highly resistant organisms. Offers life-saving therapy in serious hospital-acquired and multidrug-resistant bacterial disease.

MRP: ₹5250/-
Send Enquiry

100%

Certified Products

Secure

pAYMENTS

24/7

Customer Support

100%

Certified Products

Secure

PAYMENTS

24/7

Customer Support

About The Product

Uses

Ceftazidime: third-generation cephalosporin antibiotic which kills bacteria by inhibiting cell wall synthesis. Avibactam: new beta-lactamase inhibitor that prevents the resistance enzymes (ESBLs, Amp C, KPC, OXA-48) against ceftazidime and thus it is effective against highly resistant organisms. Offers life-saving therapy in serious hospital-acquired and multidrug-resistant bacterial disease.

Side Effects

  • Pain, redness or swelling where the injection was done Nausea, diarrhea, vomiting Dizziness or headache Itch, rash or allergy Uncommon: increased liver enzymes, alterations in kidney functions, Clostridium difficile-related diarrhea

Uses

Ceftazidime: third-generation cephalosporin antibiotic which kills bacteria by inhibiting cell wall synthesis. Avibactam: new beta-lactamase inhibitor that prevents the resistance enzymes (ESBLs, Amp C, KPC, OXA-48) against ceftazidime and thus it is effective against highly resistant organisms. Offers life-saving therapy in serious hospital-acquired and multidrug-resistant bacterial disease.

Side Effects

  • Pain, redness or swelling where the injection was done Nausea, diarrhea, vomiting Dizziness or headache Itch, rash or allergy Uncommon: increased liver enzymes, alterations in kidney functions, Clostridium difficile-related diarrhea

Indications

  • Complex urinary tract infections (cUTIs) with pyelonephritis Complex intra-abdominal infections (cIAIs) Hospital-acquired pneumonia, ventilator-associated pneumonia (HAP/VAP) Carbapenem-resistant Enterobacteriaceae (CRE) and multidrug-resistant Gram-negative bacteria infections CUTI or cIAI related bloodstream infection (bacteremia)

FAQ

Q1: How does CRYPTAZ-AV 2.5 compare with the ordinary ceftazidime injections?
A1: It has Avibactam that fights resistance by blocking beta-lactamase enzymes and is therefore effective against otherwise resistant infections.

Q2: What is the administration of CRYPTAZ-AV?
A2: It is administered intravenously (IV) in hospital/clinical supervision and is typically infused over 2 hours.

Q3: Is it applicable in patients with kidney?
A3: Yes, but it has to be adjusted in patients with renal impairment--only with a doctor.

Q4: Is it safe to children and elderly patients?
A4: It can be prescribed to adults and children over the age of 3 months with the dose prescribed by the doctor.

Indications

  • Complex urinary tract infections (cUTIs) with pyelonephritis Complex intra-abdominal infections (cIAIs) Hospital-acquired pneumonia, ventilator-associated pneumonia (HAP/VAP) Carbapenem-resistant Enterobacteriaceae (CRE) and multidrug-resistant Gram-negative bacteria infections CUTI or cIAI related bloodstream infection (bacteremia)

FAQ

Q1: How does CRYPTAZ-AV 2.5 compare with the ordinary ceftazidime injections?
A1: It has Avibactam that fights resistance by blocking beta-lactamase enzymes and is therefore effective against otherwise resistant infections.

Q2: What is the administration of CRYPTAZ-AV?
A2: It is administered intravenously (IV) in hospital/clinical supervision and is typically infused over 2 hours.

Q3: Is it applicable in patients with kidney?
A3: Yes, but it has to be adjusted in patients with renal impairment--only with a doctor.

Q4: Is it safe to children and elderly patients?
A4: It can be prescribed to adults and children over the age of 3 months with the dose prescribed by the doctor.

Request a Callback